Literature DB >> 30930336

Asymmetric dimethylarginine - a prognostic marker for transplant outcome?

Janghee Woo1,2, H Joachim Deeg3,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30930336      PMCID： PMC6442947          DOI： 10.3324/haematol.2018.212191

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system.

Authors:  Thomas Luft; Sascha Dietrich; Christine Falk; Michael Conzelmann; Michael Hess; Axel Benner; Frank Neumann; Berend Isermann; Ute Hegenbart; Anthony D Ho; Peter Dreger
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

Review 2.  New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Authors:  Sonata Jodele; Christopher E Dandoy; Kasiani C Myers; Javier El-Bietar; Adam Nelson; Gregory Wallace; Benjamin L Laskin
Journal:  Transfus Apher Sci       Date:  2016-04-25       Impact factor: 1.764

3.  Reduced mortality after allogeneic hematopoietic-cell transplantation.

Authors:  Ted A Gooley; Jason W Chien; Steven A Pergam; Sangeeta Hingorani; Mohamed L Sorror; Michael Boeckh; Paul J Martin; Brenda M Sandmaier; Kieren A Marr; Frederick R Appelbaum; Rainer Storb; George B McDonald
Journal:  N Engl J Med       Date:  2010-11-25       Impact factor: 91.245

Review 4.  Nitric oxide synthases: regulation and function.

Authors:  Ulrich Förstermann; William C Sessa
Journal:  Eur Heart J       Date:  2011-09-01       Impact factor: 29.983

5.  The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease.

Authors:  Latika Sibal; Sharad C Agarwal; Philip D Home; Rainer H Boger
Journal:  Curr Cardiol Rev       Date:  2010-05

Review 6.  Cytokine dysregulation and acute graft-versus-host disease.

Authors:  J H Antin; J L Ferrara
Journal:  Blood       Date:  1992-12-15       Impact factor: 22.113

7.  Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease.

Authors:  Sara Franceschelli; Alessio Ferrone; Mirko Pesce; Graziano Riccioni; Lorenza Speranza
Journal:  Int J Mol Sci       Date:  2013-12-16       Impact factor: 5.923

8.  Asymmetric dimethylarginine serum levels are associated with early mortality after allogeneic stem cell transplantation.

Authors:  Aleksandar Radujkovic; Hao Dai; Lambros Kordelas; Dietrich Beelen; Sivaramakrishna P Rachakonda; Carsten Müller-Tidow; Rajiv Kumar; Peter Dreger; Thomas Luft
Journal:  Haematologica       Date:  2018-12-04       Impact factor: 9.941

9.  Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study.

Authors:  Chao Xuan; Long-Qiang Xu; Qing-Wu Tian; Hui Li; Qing Wang; Guo-Wei He; Li-Min Lun
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

10.  Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle.

Authors:  Woojung Lee; Hyo Jung Lee; Han Byul Jang; Hyo-Jin Kim; Hyo-Jeong Ban; Kwang Youl Kim; Moon Suk Nam; Joo Sun Choi; Kyung-Tae Lee; Seong Beom Cho; Sang Ick Park; Hye-Ja Lee
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.